课题基金 / 基金详情

The Jackson Laboratory Center for Precision Genetics: From New Models to Novel Therapeutics

The Jackson Laboratory Center for Precision Genetics: From New Models to Novel Therapeutics
杰克逊精密遗传学实验室中心:从新模型到新疗法
批准号:
9516027
负责人:
Robert W Burgess
金额:
$199.69万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-08-15 至 2020-06-30

项目摘要

项目成果

Robert W Burgess的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
 DESCRIPTION (provided by applicant): The Jackson Laboratory (JAX) Center for Precision Genetics (JCPG) will develop and disseminate new, precise animal models of incurable and genetically complex human diseases. The JCPG will leverage JAX's long-established expertise in mammalian genetics and disease modeling as well as the human clinical samples, data and collaborations fostered by The Jackson Laboratory for Genomic Medicine (JAX-GM), its newly established clinical genomics institute. The JCPG's international, multi-disciplinary team-including geneticists and genetics technology experts, molecular and computational biologists, clinical experts in specific disease areas and world leaders in the development of precision animal models of disease-will possess the collective ability to foresee disease modeling needs as they emerge and will serve investigators in a variety of disease areas on a regional, national and international basis. Initially six projects will address intractable or incurable diseases linkd by genetic complexity, molecular genetic data and/or "humanization" that represent diverse stages of preclinical development. The JCPG will: Aim 1) Align investigator-initiated disease model research projects with institution-wide support to create efficient and goal-oriented preclinical pipelines; Aim 2) Use heuristic program development in the pilot center research projects and cores to position JAX to be a fully functional center in five years, while nevertheles achieving tangible outcomes during the pilot period; Aim 3) Embrace both realistic, cutting-edge technological platforms and ambitious high-risk, high-reward platforms as required to get the job done, i.e., advance paths to therapies for heretofore incurable diseases; and Aim 4) Through JAX's many inter-institutional collaborations, identify and engage key clinical, foundation and corporate partners, who share our vision both for specific disease objectives, to help us navigate larger center goals. Ultimately, the JCPG will generate new disease modeling processes and pipelines, data resources, research results and models that will be swiftly shared through JAX's proven dissemination pipelines to accelerate translation to medical benefit.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dissecting the Integrated Stress Response in tRNA Synthetase-Associated Neuropathies
  • 批准号:
    10647281
  • 项目类别:
  • 资助金额:
    $21.64万
  • 财政年份:
    2023
  • 负责人:
    Robert W Burgess
  • 依托单位:
Testing SARM1 as a Therapeutic Target in Multiple Forms of Charcot-Marie-Tooth Disease
  • 批准号:
    10526224
  • 项目类别:
  • 资助金额:
    $17.31万
  • 财政年份:
    2022
  • 负责人:
    Robert W Burgess
  • 依托单位:
The Genetics of the Neuromuscular Junction: Mechanisms and Disease Models
  • 批准号:
    10303668
  • 项目类别:
  • 资助金额:
    $27.78万
  • 财政年份:
    2021
  • 负责人:
    Robert W Burgess
  • 依托单位:
Exploring the Functions of tRNA Synthetases in the Nucleus and their Relationship to CMT
  • 批准号:
    10588027
  • 项目类别:
  • 资助金额:
    $3.07万
  • 财政年份:
    2020
  • 负责人:
    Robert W Burgess
  • 依托单位:
海外基金